---
title: "Jasper Therapeutics GAAP EPS of -$0.10 beats by $0.22"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296058486.md"
description: "Jasper Therapeutics GAAP EPS of -$0.10 beats by $0.22"
datetime: "2026-08-17T05:16:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296058486.md)
  - [en](https://longbridge.com/en/news/296058486.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296058486.md)
---

# Jasper Therapeutics GAAP EPS of -$0.10 beats by $0.22


### Related Stocks

- [JSPR.US](https://longbridge.com/en/quote/JSPR.US.md)

## Related News & Research

- [Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln](https://longbridge.com/en/news/295952283.md)
- [Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | JSPR Stock News](https://longbridge.com/en/news/295951622.md)
- [Jasper Therapeutics Q2 FY26 net loss narrows to $2.76 million; R&D expense drops to $5.14 million](https://longbridge.com/en/news/295950973.md)
- [These Analysts Increase Their Forecasts On Fabrinet After Q4 Results](https://longbridge.com/en/news/296244937.md)
- [Cerebras Cloud Revenue Nearly Quadrupled — But Why Did the Stock Crash 17% on "Confusing" GAAP Results?](https://longbridge.com/en/news/296000955.md)